How the FDA Created a Peptide Black Market

The FDA's stringent regulations on peptides have inadvertently fueled a thriving black market, as many Americans turn to overseas labs for these compounds. This ban, intended to safeguard public health, has ironically led to unsafe and unregulated products flooding the market. As legitimate sources dwindle, users face increased health risks from unverified substances, highlighting the need for a balanced approach to regulation that prioritizes safety without stifling access to potentially beneficial compounds.